Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Diabetes complications and comorbidities: Hypoglycemia

Journal articles and book chapters

09-10-2018 | Insulin glargine | Article

Association of patient profile with glycemic control and hypoglycemia with insulin glargine 300 U/mL in type 2 diabetes: A post hoc patient-level meta-analysis

Twigg SM et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0498-x

08-29-2018 | Hypoglycemia | Article

A post hoc pooled analysis to evaluate hypoglycemia risk with insulin glargine 300 U/mL (Gla‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in people with type 2 diabetes on a basal‐only insulin regimen

Bolli GB et al. Diabetes Obes Metab 2018. doi: 10.1111/dom.13515

08-29-2018 | Continuous glucose monitoring | Review | Article

Designing the glucose telemetry for hospital management: From bedside to the nursing station

Satyarengga M, Siddiqui T, Spanakis EK. Curr Diab Rep 2018; 18: 87. doi: 10.1007/s11892-018-1067-4

08-22-2018 | Hypoglycemia | Article

Male patients with longstanding type 2 diabetes have a higher incidence of hypoglycemia compared with female patients

Li F et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0492-3

08-18-2018 | Continuous glucose monitoring | Review | Article

Prevention and management of severe hypoglycemia and hypoglycemia unawareness: Incorporating sensor technology

Lucidi P et al. Curr Diab Rep 2018; 18: 83. doi: 10.1007/s11892-018-1065-6

08-15-2018 | Pregnancy | Review | Article

Inpatient glycemic management of the pregnant patient

Yeh T, Yeung M, Mendelsohn Curanaj FA. Curr Diab Rep 2018; 18: 73. doi: 10.1007/s11892-018-1045-x

08-15-2018 | Nephropathy | Review | Article

Inpatient glycemic management in the setting of renal insufficiency/failure/dialysis

Iyengar R, Franzese J, Gianchandani R. Curr Diab Rep 2018; 18: 75. doi: 10.1007/s11892-018-1044-y

08-08-2018 | Hypoglycemia | Article

Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: Results of the PROLOG trial

Forlenza GP et al. Diabetes Care 2018: dc180771. doi: 10.2337/dc18-0771

07-23-2018 | SGLT2 inhibitors | Review | Article

SGLT2 inhibitors in type 2 diabetes management: Key evidence and implications for clinical practice

Wilding J et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0471-8

07-19-2018 | Dapagliflozin | Article

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 24-week results from a randomized controlled trial

Methieu C et al. Diabetes Care 2018: dc180623. doi: 10.2337/dc18-0623

07-03-2018 | Hypoglycemia | Article

Association of initiation of basal insulin analogs vs neutral protamine Hagedorn insulin with hypoglycemia-related emergency department visits or hospital admissions and with glycemic control in patients with type 2 diabetes

Lipska KJ et al. JAMA 2018; 320: 53–62. doi: 10.1001/jama.2018.7993

06-30-2018 | Insulin NPH | Article

Glycemic control in hospitalized patients with diabetes receiving corticosteroids using a neutral protamine Hagedorn insulin protocol: A randomized clinical trial

Khowaja A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0468-3

06-27-2018 | Metformin | Article

Metformin monotherapy in children and adolescents with type 2 diabetes mellitus in Japan

Matsuura N et al. Diabetol Int 2018. doi: 10.1007/s13340-018-0361-3

06-26-2018 | Devices and technology | Review | Article

Technology in the management of type 1 diabetes mellitus: Current status and future prospects

Tauschmann M Hovorka R. Nat Rev Rheumatol 2018. doi: 10.1038/s41574-018-0044-y

06-24-2018 | Sotagliflozin | Article

Sotagliflozin in combination with optimized insulin therapy in adults with type 1 diabetes: The North American inTandem1 study

Buse JB et al. Diabetes Care 2018. doi: 10.2337/dc18-0343

06-24-2018 | Drug-induced diabetes | Article

Collateral damage: Insulin-dependent diabetes induced with checkpoint inhibitors

Stamatouli AM et al. Diabetes 2018. doi: 10.2337/dbi18-0002

06-23-2018 | Pregnancy | Review | Article

Intensive glycemic treatment during type 1 diabetes pregnancy: A story of (mostly) sweet success!

Murphy HR. Diabetes Care 2018. doi: 10.2337/dci18-0001

06-23-2018 | Devices and technology | Review | Article

Diabetes technology update: Use of insulin pumps and continuous glucose monitoring in the hospital

Umpierrez GE, Klonoff DC. Diabetes Care 2018. doi: 10.2337/dci18-0002

06-23-2018 | Gestational diabetes | Article

Maternal gestational diabetes mellitus and the risk of subsequent pediatric cardiovascular diseases of the offspring: A population-based cohort study with up to 18 years of follow up

Leybovitz-Haleluya N et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1176-1

06-22-2018 | Gastroparesis | Review | Article

Diabetic gastroparesis: Principles and current trends in management

Krishnasamy S, Abell TL. Diabetes Ther (2018); 9 (Suppl 1): 1. doi: 10.1007/s13300-018-0454-9

Next